Allergan recently opened a new €160 million state-of-the-art Biologics 2 facility at its Westport Campus in Co. Mayo, Ireland. The new facility will create 63 jobs and enhance Ireland’s position as a global hub for Allergans’ flagship products, including the blockbuster Botox. The new facility and famous cosmetic skin injection brand will soon fall into AbbVie’s hands with the conclusion of the ongoing regulatory approval process for AbbVie’s acquisition of Allergan anticipated in the first quar...